What if We Could Go Back in Time? Optimising Care of People With Cardiovascular, Renal, and Metabolic Conditions Using SGLT2 Inhibitors

Boehringer Ingelheim and Eli Lilly and Company |
Monday

Sponsor

Triple Action in Type 2 Diabetes Management: Canagliflozin in Focus

Menarini Group |
Tuesday

Sponsor

Translating data into insights for tailored value-based care

Roche Diabetes Care GmbH |
Monday

Sponsor

Time to act in CKD: Finerenone as a pillar of treatment in T2D patients

Bayer AG |
Thursday

Sponsor

Then and now: 100 years of making a difference in diabetes and beyond​

Novo Nordisk A/S |
Monday

Sponsor

The time is now: implementing a multidisciplinary approach to metabolic dysfunction-associated steatotic liver disease ​(MASLD*/NAFLD) management

Novo Nordisk A/S and Echosens |
Tuesday

Sponsor